Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride

NCT ID: NCT01563172

Last Updated: 2018-02-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-01

Study Completion Date

2009-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate and compare the effect of the amount of toothpaste used and brushing time on enamel strengthening (percent of surface microhardness recovery, % SMHR) and enamel fluoride uptake (EFU).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental dentifrice 0.5g, 45 seconds brushing group

Participants brush twice a daily for 45 seconds with experimental dentifrice.

Group Type EXPERIMENTAL

Sodium fluoride / silica and carbopol, 0.5g

Intervention Type DRUG

Dentifrice containing 1150 parts per million (ppm) fluoride as sodium fluoride / silica and 0.4% carbopol

Fluoride free dentifrice

Intervention Type OTHER

A non fluoride dentifrice was given to participants of each arm at washout period

Experimental dentifrice 1.5g, 45 seconds brushing group

Participants brush twice a daily for 45 seconds with experimental dentifrice.

Group Type EXPERIMENTAL

Sodium fluoride / silica and carbopol, 1.5g

Intervention Type DRUG

Dentifrice containing 1150 ppm fluoride as sodium fluoride / silica and 0.4% carbopol

Fluoride free dentifrice

Intervention Type OTHER

A non fluoride dentifrice was given to participants of each arm at washout period

Experimental dentifrice 0.5g, 2 minutes brushing group

Participants brush twice a daily for 2 minutes with experimental dentifrice.

Group Type EXPERIMENTAL

Sodium fluoride / silica and carbopol, 0.5g

Intervention Type DRUG

Dentifrice containing 1150 parts per million (ppm) fluoride as sodium fluoride / silica and 0.4% carbopol

Fluoride free dentifrice

Intervention Type OTHER

A non fluoride dentifrice was given to participants of each arm at washout period

Experimental dentifrice 1.5g, 2 minutes brushing group

Participants brush twice a daily for 2 minutes with experimental dentifrice.

Group Type EXPERIMENTAL

Sodium fluoride / silica and carbopol, 1.5g

Intervention Type DRUG

Dentifrice containing 1150 ppm fluoride as sodium fluoride / silica and 0.4% carbopol

Fluoride free dentifrice

Intervention Type OTHER

A non fluoride dentifrice was given to participants of each arm at washout period

Contol group

Participants brush twice a daily for 2 minutes with controll dentifrice.

Group Type ACTIVE_COMPARATOR

Sodium fluoride / silica and carbopol, 1.5g

Intervention Type DRUG

Dentifrice containing 250 ppm fluoride as sodium fluoride / silica and 0.4% carbopol

Fluoride free dentifrice

Intervention Type OTHER

A non fluoride dentifrice was given to participants of each arm at washout period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sodium fluoride / silica and carbopol, 0.5g

Dentifrice containing 1150 parts per million (ppm) fluoride as sodium fluoride / silica and 0.4% carbopol

Intervention Type DRUG

Sodium fluoride / silica and carbopol, 1.5g

Dentifrice containing 1150 ppm fluoride as sodium fluoride / silica and 0.4% carbopol

Intervention Type DRUG

Sodium fluoride / silica and carbopol, 1.5g

Dentifrice containing 250 ppm fluoride as sodium fluoride / silica and 0.4% carbopol

Intervention Type DRUG

Fluoride free dentifrice

A non fluoride dentifrice was given to participants of each arm at washout period

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

General and Dental Health

* Good general and dental health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or oral examination
* Have no current active caries or periodontal disease that may compromise the study or the health of the subjects
* Residency: Currently living in the Indianapolis, Indiana area

Dentures:

* Currently wearing a removable mandibular partial denture with sufficient room in the posterior buccal flange area to accommodate two enamel specimens (required dimensions 12 mm x 7 mm)
* Willing to have their denture modified to accommodate enamel test specimens and willing and capable of wearing their removable mandibular partial dentures 24 hours per day during the experimental periods
* All restorations in a good state of repair
* Salivary Flow: Have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate ≥ 0.2 mL/minute; gum base stimulated whole saliva flow rate ≥ 0.8 mL/minute)

Exclusion Criteria

* Antibiotics: Use of antibiotics two weeks prior to a treatment visit or anticipated use during the study treatment periods
* Study Scale Use: Subjects unable to measure product weights accurately using the assigned study scale as determined by the study staff (as demonstrated on or before Visit 4)
* A member of the site study staff who is directly working on the project or living in that staff's household
* Any employee of any toothpaste manufacturer or their spouse or family member
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Indiana University School of Dentistry

Indianapolis, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

https://clinicaltrials.gov/ct2/show/results/NCT01563172?term=T3158587&rank=1

Reference Type RESULT

Creeth JE, Kelly SA, Gonzalez-Cabezas C, Karwal R, Martinez-Mier EA, Lynch RJM, Bosma ML, Zero DT. Effect of toothbrushing duration and dentifrice quantity on enamel remineralisation: An in situ randomized clinical trial. J Dent. 2016 Dec;55:61-67. doi: 10.1016/j.jdent.2016.10.003. Epub 2016 Oct 4.

Reference Type DERIVED
PMID: 27717756 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

T3158587

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

In Situ Caries of Fluoride Toothpastes
NCT00708123 COMPLETED PHASE3